nach oben

European Journal of Pediatrics

Erschienen in:

18.02.2021 | COVID-19 | Review Zur Zeit gratis

Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

verfasst von: Levi Hoste, Ruben Van Paemel, Filomeen Haerynck

Erschienen in: European Journal of Pediatrics | Ausgabe 7/2021

Einloggen, um Zugang zu erhalten

Abstract

An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2 was recently published and termed pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome (in children) (MIS(-C)). We performed a systematic review and describe the epidemiological, clinical, and prognostic characteristics of 953 PIMS-TS/MIS(-C) cases in 68 records. Additionally, we studied the sensitivity of different case definitions that are currently applied. PIMS-TS/MIS(-C) presents at a median age of 8 years. Epidemiological enrichment for males (58.9%) and ethnic minorities (37.0% Black) is present. Apart from obesity (25.3%), comorbidities are rare. PIMS-TS/MIS(-C) is characterized by fever (99.4%), gastrointestinal (85.6%) and cardiocirculatory manifestations (79.3%), and increased inflammatory biomarkers. Nevertheless, 50.3% present respiratory symptoms as well. Over half of patients (56.3%) present with shock. The majority of the patients (73.3%) need intensive care treatment, including extracorporal membrane oxygenation (ECMO) in 3.8%. Despite severe disease, mortality is rather low (1.9%). Of the currently used case definitions, the WHO definition is preferred, as it is more precise, while encompassing most cases.

Conclusion: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. However, mortality rate is low and short-term outcome favorable. Long-term follow-up of chronic complications and additional clinical research to elucidate the underlying pathogenesis is crucial.

What is Known: • A novel pediatric inflammatory syndrome with multisystem involvement has been described in association with SARS-CoV-2. • To date, the scattered reporting of cases and use of different case definitions provides insufficient insight in the full clinical spectrum, epidemiological and immunological features, and prognosis.
What is New: • This systematic review illustrates the heterogeneous spectrum of PIMS-TS/MIS(-C) and its epidemiological enrichment for males, adolescents, and racial and ethnic minorities. • Despite its severe presentation, overall short-term outcome is good. • The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.

Nur mit Berechtigung zugänglich

WHO (2020) Novel coronavirus – China (2020, Jan 12). http://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/. Accessed 23 Jul 2020

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5CrossRefPubMedPubMedCentral

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team (2020) A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 382:727–733. https://doi.org/10.1056/NEJMoa2001017CrossRefPubMedPubMedCentral

Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3CrossRefPubMedPubMedCentral

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J', Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513. https://doi.org/10.1016/S0140-6736(20)30211-7CrossRefPubMedPubMedCentral

Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323:1239–1242. https://doi.org/10.1001/jama.2020.2648CrossRefPubMed

Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, Rovida F, Baldanti F, Marseglia GL (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr 2:882–889. https://doi.org/10.1001/jamapediatrics.2020.1467CrossRef

Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S (2020) Epidemiology of COVID-19 among children in China. Pediatrics 145:e20200702. https://doi.org/10.1542/peds.2020-0702CrossRefPubMed

Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D (2020) Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis 20:689–696. https://doi.org/10.1016/S1473-3099(20)30198-5CrossRefPubMedPubMedCentral

10.

Ludvigsson JF (2020) Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 109:1088–1095. https://doi.org/10.1111/apa.15270CrossRefPubMed

11.

Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P (2020) Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 395:1607–1608. https://doi.org/10.1016/S0140-6736(20)31094-1CrossRefPubMedPubMedCentral

12.

Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, Bonanomi E, D'Antiga L (2020) An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 395:1771–1778. https://doi.org/10.1016/S0140-6736(20)31103-XCrossRefPubMedPubMedCentral

13.

Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, Newburger JW, Kleinman LC, Heidemann SM, Martin AA, Singh AR, Li S, Tarquinio KM, Jaggi P, Oster ME, Zackai SP, Gillen J, Ratner AJ, Walsh RF, Fitzgerald JC, Keenaghan MA, Alharash H, Doymaz S, Clouser KN, Giuliano JS Jr, Gupta A, Parker RM, Maddux AB, Havalad V, Ramsingh S, Bukulmez H, Bradford TT, Smith LS, Tenforde MW, Carroll CL, Riggs BJ, Gertz SJ, Daube A, Lansell A, Coronado Munoz A, Hobbs CV, Marohn KL, Halasa NB, Patel MM, Randolph AG, Overcoming COVID-19 Investigators, CDC COVID-19 Response Team (2020) Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 383:334–346. https://doi.org/10.1056/NEJMoa2021680CrossRefPubMed

14.

Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, Barranco MA, Maxted AM, Rosenberg ES, Easton D, Udo T, Kumar J, Pulver W, Smith L, Hutton B, Blog D, Zucker H, New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team (2020) Multisystem inflammatory syndrome in children in New York state. N Engl J Med 383:347–358. https://doi.org/10.1056/NEJMoa2021756CrossRefPubMed

15.

Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, Ramnarayan P, Fraisse A, Miller O, Davies P, Kucera F, Brierley J, McDougall M, Carter M, Tremoulet A, Shimizu C, Herberg J, Burns JC, Lyall H, Levin M, for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (2020) Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA - J Am Med Assoc 324:259–269. https://doi.org/10.1001/jama.2020.10369CrossRef

16.

Hameed S, Elbaaly H, Reid CEL et al (2020) Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. Radiology:202543. https://doi.org/10.1148/radiol.2020202543

17.

Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R, Gillen JK, Perez MM, Soshnick SH, Conway EE Jr, Bercow A, Seiden HS, Pass RH, Ushay HM, Ofori-Amanfo G, Medar SS (2020) Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection: a multi-institutional study from New York City. J Pediatr 224:24–29. https://doi.org/10.1016/j.jpeds.2020.06.045CrossRefPubMedPubMedCentral

18.

CDC Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19), 2020. https://emergency.cdc.gov/han/2020/han00432.asp. Accessed 8 Jul 2020

19.

World Health Organization (WHO) (2020) Multisystem inflammatory syndrome in children and adolescents with COVID-19. 1–3

20.

Royal College of Health Paediatrics and Child (RCPCH) (2020) Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19. https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-inflammatory syndrome-20200501.pdf. Accessed 8 Jul 2020

21.

Wells G, Shea B, O’Connell C, et al The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 23 Jul 2020

22.

Sackett DL (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95:2S–4SCrossRefPubMed

23.

Swann OV, Holden KA, Turtle L et al (2020) Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study. medRxiv. https://doi.org/10.1101/2020.07.14.20153320

24.

Al-Aamri MA, Al-Khars FT, Alkhwaitem SJ et al (2020) A Saudi G6PD deficient girl died with pediatric multisystem inflammatory syndrome-COVID-19. medRxiv. https://doi.org/10.1101/2020.07.08.20137497

25.

Weisberg SP, Connors T, Zhu Y et al (2020) Antibody responses to SARS-CoV2 are distinct in children with MIS-C compared to adults with COVID-19. Medrxiv 2020(07):12.20151068. https://doi.org/10.1101/2020.07.12.20151068CrossRef

26.

Rostad CA, Chahroudi A, Mantus G et al (2020) Serology in children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19. medRxiv. https://doi.org/10.1101/2020.07.10.20150755

27.

Rostad CA, Chahroudi A, Mantus G, Lapp SA, Teherani M, Macoy L, Tarquinio KM, Basu RK, Kao C, Linam WM, Zimmerman MG, Shi PY, Menachery VD, Oster ME, Edupuganti S, Anderson EJ, Suthar MS, Wrammert J, Jaggi P (2020) Quantitative SARS-CoV-2 serology in children with multisystem inflammatory syndrome (MIS-C). Pediatrics 146:e2020018242. https://doi.org/10.1542/peds.2020-018242CrossRefPubMed

28.

Weisberg SP, Connors TJ, Zhu Y, Baldwin MR, Lin WH, Wontakal S, Szabo PA, Wells SB, Dogra P, Gray J, Idzikowski E, Stelitano D, Bovier FT, Davis-Porada J, Matsumoto R, Poon MML, Chait M, Mathieu C, Horvat B, Decimo D, Hudson KE, Zotti FD, Bitan ZC, la Carpia F, Ferrara SA, Mace E, Milner J, Moscona A, Hod E, Porotto M, Farber DL (2021) Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat Immunol 22:25–31. https://doi.org/10.1038/s41590-020-00826-9CrossRefPubMed

29.

Swann OV, Holden KA, Turtle L, Pollock L, Fairfield CJ, Drake TM, Seth S, Egan C, Hardwick HE, Halpin S, Girvan M, Donohue C, Pritchard M, Patel LB, Ladhani S, Sigfrid L, Sinha IP, Olliaro PL, Nguyen-van-Tam JS, Horby PW, Merson L, Carson G, Dunning J, Openshaw PJM, Baillie JK, Harrison EM, Docherty AB, Semple MG (2020) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study. BMJ 370:m3249. https://doi.org/10.1136/bmj.m3249CrossRefPubMed

30.

Rivera-Figueroa EI, Santos R, Simpson S, Garg P (2020) Incomplete Kawasaki disease in a child with Covid-19. Indian Pediatr 57:680–681CrossRefPubMedPubMedCentral

31.

Schnapp A, Abulhija H, Maly A, Armoni-Weiss G, Levin Y, Faitatziadou SM, Molho-Pessach V (2020) Introductory histopathologic findings may shed light on COVID19 pediatric hyperinflammatory shock syndrome. J Eur Acad Dermatol Venereol 34:e665–e667. https://doi.org/10.1111/jdv.16749CrossRefPubMed

32.

Chiu JS, Lahoud-Rahme M, Schaffer D, Cohen A, Samuels-Kalow M (2020) Kawasaki disease features and myocarditis in a patient with COVID-19. Pediatr Cardiol 41:1–3. https://doi.org/10.1007/s00246-020-02393-0CrossRef

33.

Rodriguez-Gonzalez M, Sanchez-Codez M, Gutierrez-Rosa I, Castellano-Martinez A, Rodriguez-Benitez AR-CP (2020) New onset severe right ventricular failure associated with COVID-19 in a young infant without previous heart disease. Cardiol Young:1–4. https://doi.org/10.1017/S1047951120001857

34.

Giannattasio A, Maglione M, Zenzeri L, Mauro A, di Mita O, Iodice RM, Tipo V (2020) A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease? J Med Virol 93:112–114. https://doi.org/10.1002/jmv.26189CrossRefPubMed

35.

Dasgupta K, Finch S (2020) A case of pediatric multisystem inflammatory syndrome temporally associated with COVID-19 in South Dakota. S D Med 73:246–251PubMed

36.

Bapst T, Romano F, Müller M, Rohr M (2020) Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme. BMJ Case Rep 13. https://doi.org/10.1136/bcr-2020-236986

37.

Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, Nguyen EL, Barsh GR, Maskatia S, Mathew R (2020) COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 10:537–540. https://doi.org/10.1542/hpeds.2020-0123CrossRefPubMed

38.

Haigh K, Syrimi Z, Irvine S et al (2020) Hyperinflammation with COVID-19: The key to patient deterioration? Clin Infect Pract 7-8:7–8. https://doi.org/10.1016/j.clinpr.2020.100033CrossRef

39.

Vari D, Miller J, Rellosa N et al (2020) Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: Retrospective diagnosis of a puzzling presentation. A case report. Prog Pediatr Cardiol 58:101270. https://doi.org/10.1016/j.ppedcard.2020.101270CrossRefPubMedPubMedCentral

40.

Nguyen DC, Haydar H, Pace ER, Zhang XS, Dobbs KR (2020) Pediatric case of severe COVID-19 with shock and multisystem inflammation. Cureus 12:e8915. https://doi.org/10.7759/cureus.8915CrossRefPubMedPubMedCentral

41.

Balasubramanian S, Nagendran TM, Ramachandran B, Ramanan AV (2020) Hyper-inflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr 57:681–683CrossRefPubMedPubMedCentral

42.

Puyó V, Moreno L, Díaz de Heredia D et al (2020) Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome. An Pediatr (Barc) 93:132–133. https://doi.org/10.1016/j.anpedi.2020.05.002CrossRef

43.

Klocperk A, Parackova Z, Dissou J, Malcova H, Pavlicek P, Vymazal T, Dolezalova P, Sediva A (2020) Case report: systemic inflammatory response and fast recovery in a pediatric patient with COVID-19. Front Immunol 11:1665. https://doi.org/10.3389/fimmu.2020.01665CrossRefPubMedPubMedCentral

44.

Cazzaniga M, Baselli LA, Cimaz R, Guez SS, Pinzani R, Dellepiane RM (2020) SARS-COV-2 Infection and Kawasaki disease: case report of a hitherto unrecognized association. Front Pediatr 8:398. https://doi.org/10.3389/fped.2020.00398CrossRefPubMedPubMedCentral

45.

Bahrami A, Vafapour M, Moazzami B, Rezaei N (2020) Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran. J Paediatr Child Health. https://doi.org/10.1111/jpc.15048

46.

Cogan E, Foulon P, Cappeliez O, Dolle N, Vanfraechem G, de Backer D (2020) Multisystem inflammatory syndrome with complete Kawasaki disease features associated with SARS-CoV-2 infection in a young adult. A Case Report. Front Med 7:428. https://doi.org/10.3389/fmed.2020.00428CrossRef

47.

Regev T, Antebi M, Eytan D, Shachor-Meyouhas Y, Ilivitzki A, Aviel YB, Ben-Ari J (2020) Pediatric inflammatory multisystem syndrome with central nervous system involvement and hypocomplementemia following SARS-COV-2 infection. Pediatr Infect Dis J 39:E206–E207. https://doi.org/10.1097/INF.0000000000002804CrossRefPubMed

48.

Raut S, Roychowdhoury S, Bhakta S, Sarkar M, Nandi M (2020) Incomplete Kawasaki disease as presentation of COVID-19 infection in an infant: a case report. J Trop Pediatr. https://doi.org/10.1093/tropej/fmaa047

49.

Bhansali S, Minocha P, Phoon C, Henry G, Chakravarti S, Ramirez M, Bhatla P (2020) Cardiac involvement in a pediatric patient with COVID-19: looking beyond the nonspecific global cardiac injury. Echocardiography. 37:1488–1491. https://doi.org/10.1111/echo.14814CrossRefPubMed

50.

Gupta A, Gill A, Sharma M, Garg M (2020) Multi-system inflammatory syndrome in a child mimicking Kawasaki disease. J Trop Pediatr. https://doi.org/10.1093/tropej/fmaa060

51.

Dolinger MT, Person H, Smith R, Jarchin L, Pittman N, Dubinsky MC, Lai J (2020) Pediatric Crohn’s disease and multisystem inflammatory syndrome in children (MIS-C) and COVID-19 treated with infliximab. J Pediatr Gastroenterol Nutr 71:153–155. https://doi.org/10.1097/MPG.0000000000002809CrossRefPubMed

52.

Deza Leon MP, Redzepi A, McGrath E, Abdel-Haq N, Shawaqfeh A, Sethuraman U, Tilford B, Chopra T, Arora H, Ang J, Asmar B (2020) COVID-19 associated pediatric multi-system inflammatory syndrome. J Pediatric Infect Dis Soc 9:407–408. https://doi.org/10.1093/jpids/piaa061CrossRefPubMed

53.

Acharyya BC, Acharyya S, Das D (2020) Novel coronavirus mimicking Kawasaki disease in an infant. Indian Pediatr 57:753–754CrossRefPubMedPubMedCentral

54.

Rauf A, Vijayan A, John ST, Krishnan R, Latheef A (2020) Multisystem inflammatory syndrome with features of atypical Kawasaki disease during COVID-19 pandemic. Indian J Pediatr 87:745–747. https://doi.org/10.1007/s12098-020-03357-1CrossRefPubMedPubMedCentral

55.

Trogen B, Gonzalez FJ, Shust GF (2020) COVID-19-associated myocarditis in an adolescent. Pediatr Infect Dis J:E204–E205. https://doi.org/10.1097/INF.0000000000002788

56.

Yozgat CY, Uzuner S, Duramaz BB et al (2020) Dermatological manifestation of pediatrics multisystem inflammatory syndrome associated with COVID-19 in a 3-year-old girl. Dermatol Ther:e13770. https://doi.org/10.1111/dth.13770

57.

Greene AG, Saleh M, Roseman E, Sinert R (2020) Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C). Am J Emerg Med 38:2492.e5–2492.e6. https://doi.org/10.1016/j.ajem.2020.05.117CrossRef

58.

Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis KG (2020) Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases. Gastroenterology. 159:1571–1574.e2. https://doi.org/10.1053/j.gastro.2020.05.079CrossRefPubMed

59.

Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S, Auriau J, Grimaud M, Oualha M, Beghetti M, Wacker J, Ovaert C, Hascoet S, Selegny M, Malekzadeh-Milani S, Maltret A, Bosser G, Giroux N, Bonnemains L, Bordet J, di Filippo S, Mauran P, Falcon-Eicher S, Thambo JB, Lefort B, Moceri P, Houyel L, Renolleau S, Bonnet D (2020) Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 142:429–436. https://doi.org/10.1161/CIRCULATIONAHA.120.048360CrossRefPubMed

60.

Joshi K, Kaplan D, Bakar A, Jennings JF, Hayes DA, Mahajan S, Misra N, Mitchell E, Sweberg TM, Taylor MD, Capone CA (2020) Cardiac dysfunction and shock in pediatric patients with COVID-19. JACC Case Rep 2:1267–1270. https://doi.org/10.1016/j.jaccas.2020.05.082CrossRefPubMedPubMedCentral

61.

Toubiana J, Poirault C, Corsia A, Bajolle F, Fourgeaud J, Angoulvant F, Debray A, Basmaci R, Salvador E, Biscardi S, Frange P, Chalumeau M, Casanova JL, Cohen JF, Allali S (2020) Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ 369:m2094. https://doi.org/10.1136/bmj.m2094CrossRefPubMedPubMedCentral

62.

Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D, Leruez-Ville M, Quartier P, Léger PL, Geslain G, Semaan N, Moulin F, Bendavid M, Jean S, Poncelet G, Renolleau S, Oualha M (2020) Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care 10:69. https://doi.org/10.1186/s13613-020-00690-8CrossRefPubMedPubMedCentral

63.

Cheung EW, Zachariah P, Gorelik M, Boneparth A, Kernie SG, Orange JS, Milner JD (2020) Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York City. JAMA - J Am Med Assoc 324:294–296. https://doi.org/10.1001/jama.2020.10374CrossRef

64.

Pouletty M, Borocco C, Ouldali N, Caseris M, Basmaci R, Lachaume N, Bensaid P, Pichard S, Kouider H, Morelle G, Craiu I, Pondarre C, Deho A, Maroni A, Oualha M, Amoura Z, Haroche J, Chommeloux J, Bajolle F, Beyler C, Bonacorsi S, Carcelain G, Koné-Paut I, Bader-Meunier B, Faye A, Meinzer U, Galeotti C, Melki I (2020) Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): A multicentre cohort. Ann Rheum Dis 79:999–1006. https://doi.org/10.1136/annrheumdis-2020-217960CrossRefPubMed

65.

Ramcharan T, Nolan O, Lai CY et al (2020) Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital. Pediatr Cardiol:1–11. https://doi.org/10.1007/s00246-020-02391-2

66.

Riollano-Cruz M, Akkoyun E, Briceno-Brito E, Kowalsky S, Reed J, Posada R, Sordillo EM, Tosi M, Trachtman R, Paniz-Mondolfi A (2020) Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19: a New York City experience. J Med Virol 93:424–433. https://doi.org/10.1002/jmv.26224CrossRefPubMed

67.

Chiotos K, Bassiri H, Behrens EM, Blatz AM, Chang J, Diorio C, Fitzgerald JC, Topjian A, John ARO (2020) Multisystem inflammatory syndrome in children during the COVID-19 pandemic: a case series. J Pediatric Infect Dis Soc 9:393–398. https://doi.org/10.1093/jpids/piaa069CrossRefPubMed

68.

Waltuch T, Gill P, Zinns LE, Whitney R, Tokarski J, Tsung JW, Sanders JE (2020) Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department. Am J Emerg Med 38:2246.e3–2246.e6. https://doi.org/10.1016/j.ajem.2020.05.058CrossRef

69.

Blondiaux E, Parisot P, Redheuil A et al (2020) Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19: case series. Radiology 202288. https://doi.org/10.1148/radiol.2020202288

70.

Dallan C, Romano F, Siebert J, Politi S, Lacroix L, Sahyoun C (2020) Septic shock presentation in adolescents with COVID-19. Lancet Child Adolesc Health 4:e21–e23. https://doi.org/10.1016/S2352-4642(20)30164-4CrossRefPubMedPubMedCentral

71.

Foong Ng K, Kothari T, Bandi S et al (2020) COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection. J Med Virol 92:2880–2886. https://doi.org/10.1002/jmv.26206CrossRef

72.

Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S, Montin D (2020) SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics. 146:e20201711. https://doi.org/10.1542/peds.2020-1711CrossRefPubMed

73.

Labé P, Ly A, Sin C, Nasser M, Chapelon-Fromont E, Ben Saïd P, Mahé E (2020) Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children. J Eur Acad Dermatol Venereol 34:e539–e541. https://doi.org/10.1111/jdv.16666CrossRefPubMed

74.

Schupper A, Yaeger K, Morgenstern P (2020) Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Childs Nerv Syst 36:1579–1580. https://doi.org/10.1007/s00381-020-04755-8CrossRefPubMedPubMedCentral

75.

Rogo T, Mathur K, Purswani M (2020) Systemic inflammation with cardiac involvement in pediatric patients with evidence of COVID-19 in a community hospital in the Bronx, NY. J Pediatric Infect Dis Soc 9:502–503. https://doi.org/10.1093/jpids/piaa087CrossRefPubMed

76.

Abdel-Mannan O, Eyre M, Löbel U et al (2020) Neurologic and radiographic findings associated with COVID-19 infection in children. JAMA Neurol:E1–E6. https://doi.org/10.1001/jamaneurol.2020.2687

77.

Ferrero P, Piazza I, Bonino C, Ciuffreda M (2020) Patterns of myocardial involvement in children during COVID-19 pandemic: early experience from northern Italy. Ann Pediatr Cardiol 13:230–233. https://doi.org/10.4103/apc.APC_77_20CrossRefPubMedPubMedCentral

78.

Davies P, Evans C, Kanthimathinathan HK, Lillie J, Brierley J, Waters G, Johnson M, Griffiths B, du Pré P, Mohammad Z, Deep A, Playfor S, Singh D, Inwald D, Jardine M, Ross O, Shetty N, Worrall M, Sinha R, Koul A, Whittaker E, Vyas H, Scholefield BR, Ramnarayan P (2020) Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health 4:669–677. https://doi.org/10.1016/S2352-4642(20)30215-7CrossRefPubMedPubMedCentral

79.

Vergnano S, Alders N, Armstrong C, Bamber AR, Bandi S, Evans JA, Hajiani N, Kenny J, Kucera F, Tometzki A, Uzun O, Wilkinson N, Ramanan AV (2020) Severe refractory Kawasaki disease in seven infants in the COVID-19 era. Lancet Rheumatol 2:e520. https://doi.org/10.1016/S2665-9913(20)30231-9CrossRefPubMedPubMedCentral

80.

Kest H, Kaushik A, DeBruin W, Colletti M, Goldberg D (2020) Multisystem inflammatory syndrome in children (MIS-C) associated with 2019 novel coronavirus (SARS-CoV-2) infection. Case Rep Pediatr 2020:8875987–8875984. https://doi.org/10.1155/2020/8875987CrossRefPubMedPubMedCentral

81.

Lee PY, Day-Lewis M, Henderson LA, Friedman KG, Lo J, Roberts JE, Lo MS, Platt CD, Chou J, Hoyt KJ, Baker AL, Banzon TM, Chang MH, Cohen E, de Ferranti SD, Dionne A, Habiballah S, Halyabar O, Hausmann JS, Hazen MM, Janssen E, Meidan E, Nelson RW, Nguyen AA, Sundel RP, Dedeoglu F, Nigrovic PA, Newburger JW, Son MBF (2020) Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children. J Clin Invest 130:5942–5950. https://doi.org/10.1172/JCI141113CrossRefPubMedPubMedCentral

82.

Moraleda C, Serna-Pascual M, Soriano-Arandes A, Simó S, Epalza C, Santos M, Grasa C, Rodríguez M, Soto B, Gallego N, Ruiz Y, Urretavizcaya-Martínez M, Pareja M, Sanz-Santaeufemia FJ, Fumadó V, Lanaspa M, Jordan I, Prieto L, Belda S, Toral-Vázquez B, Rincón E, Gil-Villanueva N, Méndez-Echevarría A, Castillo-Serrano A, Rivière JG, Soler-Palacín P, Rojo P, Tagarro A, EPICO-AEP Working Group (2020) Multi-inflammatory syndrome in children related to SARS-CoV-2 in Spain. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa1042

83.

Diorio C, Henrickson SE, Vella LA, McNerney KO, Chase J, Burudpakdee C, Lee JH, Jasen C, Balamuth F, Barrett DM, Banwell BL, Bernt KM, Blatz AM, Chiotos K, Fisher BT, Fitzgerald JC, Gerber JS, Gollomp K, Gray C, Grupp SA, Harris RM, Kilbaugh TJ, John ARO, Lambert M, Liebling EJ, Paessler ME, Petrosa W, Phillips C, Reilly AF, Romberg ND, Seif A, Sesok-Pizzini DA, Sullivan KE, Vardaro J, Behrens EM, Teachey DT, Bassiri H (2020) Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest 130:5967–5975. https://doi.org/10.1172/JCI140970CrossRefPubMedPubMedCentral

84.

Wolfler A, Mannarino S, Giacomet V, Camporesi A, Zuccotti G (2020) Acute myocardial injury: a novel clinical pattern in children with COVID-19. Lancet Child Adolesc Health 4:e26–e27. https://doi.org/10.1016/S2352-4642(20)30168-1CrossRefPubMedPubMedCentral

85.

Dhanalakshmi K, Balasubramanian S, Madhusudan M et al (2020) Epidemiological and clinical profile of pediatric inflammatory multisystem syndrome - temporally associated with SARS-CoV-2 (PIMS-TS) in Indian children. Indian Pediatr 57:1010–1014CrossRefPubMedPubMedCentral

86.

Capone CA, Subramony A, Sweberg T, Schneider J, Shah S, Rubin L, Schleien C, Northwell Health COVID-19 Research Consortium, Epstein S, Johnson JC, Kessel A, Misra N, Mitchell E, Palumbo N, Rajan S, Rocker J, Williamson K, Davidson KW (2020) Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection. J Pediatr 224:141–145. https://doi.org/10.1016/j.jpeds.2020.06.044CrossRefPubMedPubMedCentral

87.

Deza Leon MP, Redzepi A, McGrath E, Abdel-Haq N, Shawaqfeh A, Sethuraman U, Tilford B, Chopra T, Arora H, Ang J, Asmar B (2020) COVID-19-associated pediatric multisystem inflammatory syndrome. J Pediatric Infect Dis Soc 9:407–408. https://doi.org/10.1093/jpids/piaa061CrossRefPubMed

88.

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26:1017–1032. https://doi.org/10.1038/s41591-020-0968-3CrossRefPubMed

89.

de Souza TH, Nadal JA, Nogueira RJN et al (2020) Clinical manifestations of children with COVID-19: a systematic review. Pediatr Pulmonol 55:1892–1899. https://doi.org/10.1002/ppul.24885CrossRefPubMed

90.

Hoang A, Chorath K, Moreira A, Evans M, Burmeister-Morton F, Burmeister F, Naqvi R, Petershack M, Moreira A (2020) COVID-19 in 7780 pediatric patients: a systematic review. EClinicalMedicine 24:100433. https://doi.org/10.1016/j.eclinm.2020.100433.eCollection2020JulCrossRefPubMedPubMedCentral

91.

Carsetti R, Quintarelli C, Quinti I, Piano Mortari E, Zumla A, Ippolito G, Locatelli F (2020) The immune system of children: the key to understanding SARS-CoV-2 susceptibility? Lancet Child Adolesc Health 4:414–416. https://doi.org/10.1016/S2352-4642(20)30135-8CrossRefPubMedPubMedCentral

92.

Brodin P (2020) Why is COVID-19 so mild in children? Acta Paediatr 109:1082–1083. https://doi.org/10.1111/apa.15271CrossRefPubMed

93.

Ruggiero A, Attinà G, Chiaretti A (2020) Additional hypotheses about why COVID-19 is milder in children than adults. Acta Paediatr 109:1690. https://doi.org/10.1111/apa.15328CrossRefPubMed

94.

Fischer A (2020) Resistance of children to Covid-19. How? Mucosal Immunol 13:563–565. https://doi.org/10.1038/s41385-020-0303-9CrossRefPubMedPubMedCentral

95.

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J (2020) SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med 382:1177–1179. https://doi.org/10.1056/NEJMc2001737CrossRefPubMedPubMedCentral

96.

Kanegaye JT, Wilder MS, Molkara D, Frazer JR, Pancheri J, Tremoulet AH, Watson VE, Best BM, Burns JC (2009) Recognition of a Kawasaki disease shock syndrome. Pediatrics 123:e783–e789. https://doi.org/10.1542/peds.2008-1871CrossRefPubMed

97.

Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP (2008) Kawasaki disease in a pediatric intensive care unit: a case-control study. Pediatrics 122:e786–e790. https://doi.org/10.1542/peds.2008-1275CrossRefPubMed

98.

McCrindle BW, Rowley AH, Newburger JW et al (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999. https://doi.org/10.1161/CIR.0000000000000484CrossRefPubMed

99.

Sokolovsky S, Soni P, Hoffman T, Kahn P, Scheers-Masters J (2020) COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult. Am J Emerg Med 39:253.e1–253.e2. https://doi.org/10.1016/j.ajem.2020.06.053CrossRef

100.

Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 20:355–362. https://doi.org/10.1038/s41577-020-0331-4CrossRefPubMedPubMedCentral

101.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034. https://doi.org/10.1016/S0140-6736(20)30628-0CrossRefPubMedPubMedCentral

102.

Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S, Cousin N, Durand A, el Kalioubie A, Favory R, Girardie P, Houard M, Jaillette E, Jourdain M, Ledoux G, Mathieu D, Moreau AS, Niles C, Nseir S, Onimus T, Préau S, Robriquet L, Rouzé A, Simonnet A, Six S, Toussaint A, Dupont A, Bauters A, Zawadzki C, Paris C, Trillot N, Wibaut B, Hochart A, Marichez C, Dalibard V, Vanderziepe S, Bourgeois L, Gaul A, Jospin A, Stepina N, Pradines B, Tournoys A, Brousseau T, Rémy M, Hutt A (2020) Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence. Circulation 142:184–186CrossRefPubMed

103.

Gruber C, Patel R, Trachman R et al (2020) Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell 183:982–995.e14. https://doi.org/10.1016/j.cell.2020.09.034CrossRefPubMedPubMedCentral

104.

Consiglio CR, Cotugno N, Sardh F et al (2020) The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell 183:968–981.e7. https://doi.org/10.1016/j.cell.2020.09.016CrossRefPubMedPubMedCentral

Titel: Multisystem inflammatory syndrome in children related to COVID-19: a systematic review
verfasst von: Levi Hoste
Ruben Van Paemel
Filomeen Haerynck
Publikationsdatum: 18.02.2021
Verlag: Springer Berlin Heidelberg
Schlagwort: COVID-19
Erschienen in: European Journal of Pediatrics / Ausgabe 7/2021
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-021-03993-5

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

Abstract

Neu im Fachgebiet Pädiatrie

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Update Pädiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2021

Are psychological symptoms a risk factor for musculoskeletal pain in adolescents?

Motor development in children and adolescents: role of body mass index and socioeconomic status

Endoscopic endonasal repair of complete bilateral choanal atresia in neonates

Functional gastrointestinal disorders in children: agreement between Rome III and Rome IV diagnoses

Serum NGAL, BNP, PTH, and albumin do not improve glomerular filtration rate estimating formulas in children

The impact of lockdown on pediatric ED visits and hospital admissions during the COVID19 pandemic: a multicenter analysis and review of the literature

Neu im Fachgebiet Pädiatrie

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Update Pädiatrie